XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Feb. 28, 2023
Feb. 28, 2022
Operating Activities:    
Net income $ 64,252 $ 61,991
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 35,443 32,701
Allowance for doubtful accounts (49) 12
Loss on sale of property and equipment 297 724
Deferred income taxes (737) (2,124)
Equity in losses of unconsolidated affiliates 73 24
Stock-based compensation 11,239 8,674
Change in operating assets and liabilities:    
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals (6,513) (19,503)
Merchandise inventories 15,310 (80,608)
Accounts payable (2,634) (9,811)
Net cash provided by (used in) operating activities 116,681 (7,920)
Investing Activities:    
Proceeds from the disposal of Aeropost, net of divested cash 0 4,959
Additions to property and equipment (53,016) (60,468)
Purchases of short-term investments (47,500) (17,658)
Proceeds from settlements of short-term investments 4,301 41,075
Proceeds from settlements of long-term investments 0 1,484
Proceeds from disposal of property and equipment 137 77
Net cash used in investing activities (96,078) (30,531)
Financing Activities:    
Proceeds from long-term bank borrowings 33,712 30,180
Repayment of long-term bank borrowings (16,994) (10,969)
Proceeds from short-term bank borrowings 301 20,179
Repayment of short-term bank borrowings 0 (4,488)
Cash dividend payments (14,260) (13,275)
Purchase of treasury stock (5,819) (3,784)
Net cash provided by (used in) financing activities (3,060) 17,843
Effect of exchange rate changes on cash and cash equivalents and restricted cash 11,636 42
Net increase (decrease) in cash, cash equivalents 29,179 (20,566)
Cash, cash equivalents and restricted cash at beginning of period 251,373 215,479
Cash, cash equivalents and restricted cash at end of period 280,552 194,913
Supplemental disclosure of noncash investing activities:    
Capital expenditures accrued, but not yet paid 3,937 8,369
Dividends declared but not yet paid 14,456 13,430
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 260,927 178,705
Short-term restricted cash 9,110 4,172
Long-term restricted cash 10,515 12,036
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 280,552 $ 194,913